Endocrine-disrupting effects of spironolactone in female western mosquitofish, Gambusia affinis

Environmental Toxicology and Chemistry

Volumn 30, Issue 6, 2011, Pages 1376-1382

  Raut, Samiksha A ^a   Howell, W Mike ^b   Angus, Robert A ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b SAMFORD UNIVERSITY   (United States)

Author keywords

Androgen; Antiandrogen; Diuretic; Endocrine disruptor; Masculinization

Indexed keywords

ANDROGEN; ANTIANDROGEN; DIURETIC; ENDOCRINE DISRUPTOR; MASCULINIZATION;

EFFLUENT TREATMENT; EFFLUENTS; FINS (HEAT EXCHANGE); GENE EXPRESSION; WASTEWATER; WASTEWATER TREATMENT; WATER TREATMENT PLANTS;

FISH;

ALDOSTERONE ANTAGONIST; DIURETIC AGENT; ENDOCRINE DISRUPTOR; SPIRONOLACTONE; VITELLOGENIN;

ANDROGEN; ANTAGONISM; CYPRINID; DOSE-RESPONSE RELATIONSHIP; DRUG; ENDOCRINE DISRUPTOR; GENE EXPRESSION; MASCULINIZATION; PUBLIC HEALTH; TEMPORAL ANALYSIS; WASTEWATER; WILD POPULATION;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; EFFLUENT; FEMALE; FIN (ORGAN); FISH; GAMBUSIA AFFINIS; MASCULINITY; NONHUMAN; PRIORITY JOURNAL; WASTE WATER TREATMENT PLANT;

ALDOSTERONE ANTAGONISTS; ANDROGEN ANTAGONISTS; ANDROGENS; ANIMAL FINS; ANIMALS; CYPRINODONTIFORMES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCRINE DISRUPTORS; ENDOCRINE SYSTEM; FEMALE; GENE EXPRESSION; GONADAL STEROID HORMONES; GROWTH AND DEVELOPMENT; SEXUAL MATURATION; SPIRONOLACTONE; VIRILISM; VITELLOGENINS; WATER POLLUTANTS, CHEMICAL;

GAMBUSIA AFFINIS;

EID: 79955707333     PISSN: 07307268     EISSN: 15528618     Source Type: Journal    
DOI: 10.1002/etc.504     Document Type: Article

References (48)

1. Hotchkiss AK, Rider CV, Blystone CR, Wilson VS, Hartig PC, Ankley GT, Foster PM, Gray CL, Gray LE. 2008. Fifteen years after "Wingspread"-Environmental endocrine disrupters and human and wildlife health: where we are today and where we need to go. Toxicol Sci 105: 235-259.
2. Celiz MD, Tso J, Aga DS. 2009. Pharmaceutical metabolites in the environment: Analytical challenges and ecological risks. Environ Toxicol Chem 28: 2473-2484.
3. Watkinson AJ, Murby EJ, Kolpin DW, Costanzo SD. 2009. The occurrence of antibiotics in an urban watershed: From wastewater to drinking water. Sci Total Environ 407: 2711-2723.
4. Brown KD, Kulis J, Thomson B, Chapman TH, Mawhinney DB. 2006. Occurrence of antibiotics in hospital, residential, and dairy effluent, municipal wastewater, and the Rio Grande in New Mexico. Sci Total Environ 366: 772-783.
5. Larsson DG, de Pedro C, Paxeus N. 2007. Effluent from drug manufactures contains extremely high levels of pharmaceuticals. J Hazard Mater 148: 751-755.
6. Holm JV, Rugge K, Bjerg PL, Christensen TH. 1995. Occurrence and distribution of pharmaceutical organic-compounds in the groundwater downgradient of a landfill (Grindsted, Denmark). Environ Sci Technol 29: 1415-1420.
7. Berninger JP, Brooks BW. 2010. Leveraging mammalian pharmaceutical toxicology and pharmacology data to predict chronic fish responses to pharmaceuticals. Toxicol Lett 193: 69-78.
8. Ternes TA, Kreckel P, Mueller J. 1999. Behaviour and occurrence of estrogens in municipal sewage treatment plants-II. Aerobic batch experiments with activated sludge. Sci Total Environ 225: 91-99.
9. Gros M, Petrović M, Barceló D. 2007. Wastewater treatment plants as a pathway for aquatic contamination by pharmaceuticals in the Ebro River basin (northeast Spain). Environ Toxicol Chem 26: 1553-1562.
10. Fent K, Weston AA, Caminada 2006. Ecotoxicology of human pharmaceuticals. Aquat Toxicol 76: 122-159.
11. Desbrow C, Routledge EJ, Grighty GC, Sumpter JP, Waldock M. 1998. Identification of estrogenic chemicals in STW effluent. 1. Chemical fractionation and in vitro biological screening. Environ Sci Technol 32: 1549-1558.
12. Gibson R, Smith MD, Spary CJ, Tyler CR, Hill EM. 2005. Mixtures of estrogenic contaminants in bile of fish exposed to wastewater treatment works effluents. Environ Sci Technol 39: 2461-2471.
13. Shultz S, Baral HS, Charman S, Cunningham AA, Das D, Ghalsasi GR, Goudar MS, Green RE, Jones A, Nighot P, Pain DJ, Prakash V. 2004. Diclofenac poisoning is widespread in declining vulture populations across the Indian subcontinent. Proc Biol Sci 271 (Suppl 6): S458-460.
14. Taggart MA, Senacha KR, Green RE, Jhala YV, Raghavan B, Rahmani AR, Cuthbert R, Pain DJ, Meharg AA. 2007. Diclofenac residues in carcasses of domestic ungulates available to vultures in India. Environ Int 33: 759-765.
15. Green RE, Taggart MA, Senacha KR, Raghavan B, Pain DJ, Jhala Y, Cuthbert R. 2007. Rate of decline of the oriental white-backed vulture population in India estimated from a survey of diclofenac residues in carcasses of ungulates. PLoS ONE 2: e686.
16. Brooks BW, Foran CM, Richards SM, Weston J, Turner PK, Stanley JK, Solomon KR, Slattery M, La Point TW. 2003. Aquatic ecotoxicology of fluoxetine. Toxicol Lett 142: 169-183.
17. Runnalls TJ, Hala DN, Sumpter JP. 2007. Preliminary studies into the effects of the human pharmaceutical Clofibric acid on sperm parameters in adult fathead minnow. Aquat Toxicol 84: 111-118.
18. Gravel A, Vijayan MM. 2007. Non-steroidal anti-inflammatory drugs disrupt the heat shock response in rainbow trout. Aquat Toxicol 81: 197-206.
19. Howell WM, Hunsinger RN, Blanchard PD. 1994. Paradoxical masculinization of female western mosquitofish during exposure to spironolactone. Progr Fish-Cult 56: 51-55.
20. Turner CL. 1942. A quantitative study of the effects of different concentrations of ethynyl testosterone and methyl testosterone in the production of gonopodia in females of Gambusia affinis Physiol Zool 15: 263-280.
21. Angus RA, McNatt HB, Howell WM, Peoples SD. 2001. Gonopodium development in normal male and 11-ketotestosterone-treated female mosquitofish (Gambusia affinis): A quantitative study using computer image analysis. Gen Comp Endocr 123: 222-234.
22. Stanko JP. 2005. Reproductive and developmental effects of bioactive constituents of pulp mill effluent on female mosquitofish, Gambusia affinis. PhD thesis. University of Alabama at Birmingham, Birmingham, Alabama, USA.
23. Lazier CB, Langley S, Ramsey NB, Wright JM. 1996. Androgen inhibition of vitellogenin gene expression in tilapia (Oreochromis niloticus). Gen Comp Endocrinol 104: 321-329.
24. Nahata MC, Morosco RS, Hipple TF. 1993. Stability of spironolactone in an extemporaneously prepared suspension at two temperatures. Ann Pharmacother 27: 1198-1199.
25. Carlander KD. 1977. Handbook of Freshwater Fishery Biology Vol. 2 Iowa State University Press, Ames, IA, USA.
26. Raut SA, Angus RA. 2010. Triclosan has endocrine-disrupting effects in male western mosquitofish, Gambusia affinis Environ Toxicol Chem 29: 1287-1291.
27. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2-DeltaDeltaCT method. Methods 25: 402-408.
28. Sone K, Hinago M, Itamoto M, Katsu Y, Watanabe H, Urushitani H, Tooi O, Guillette LJ, Iguchi T. 2005. Effects of an androgenic growth promoter 17 beta-trenbolone on masculinization of mosquitofish (Gambusia affinis Affinis). Gen Comp Endocr 143: 151-160.
29. Ogino Y, Katoh H, Yamada G. 2004. Androgen dependent development of a modified anal fin, gonopodium, as a model to understand the mechanism of secondary sexual character expression in vertebrates. FEBS Lett 575: 119-126.
30. McCormick SD, Regish A, O'Dea MF, Shrimpton JM. 2008. Are we missing a mineralocorticoid in teleost fish? Effects of cortisol, deoxycorticosterone and aldosterone on osmoregulation, gill Na+, K+ -ATPase activity and isoform mRNA levels in Atlantic salmon. Gen Comp Endocrinol 157: 35-40.
31. Churchill PC, Malvin RL, Churchill MC. 1985. Lack of renal effects of DOCA, ACTH, spironolactone, and angiotensin II in Squalus sacanthias. J Exp Zool 234: 17-22.
32. Corvol P, Mahoudeau JA, Valcke JC, Menard J, Bricaire H. 1976. Sexual side-effects of spironolactones. Possible mechanisms of their anti-androgen action. Nouv Presse Med 5: 691-694.
33. Nirdé P, Térouanne B, Gallais N, Sultan C, Auzou G. 2001. Antimineralocorticoid 11β-substituted spirolactones exhibit androgen receptor agonistic activity: A structure function study. Mol Pharmacol 59: 1307-1313.
34. Tremblay MR, Luu-The V, Leblanc G, Noel P, Breton E, Labrie F, Poirier D. 1999. Spironolactone-related inhibitors of type II 17beta-hydroxysteroid dehydrogenase: chemical synthesis, receptor binding affinities, and proliferative/antiproliferative activities. Bioorg Med Chem 7: 1013-1023.
35. Jenkins RL, Wilson EM, Angus RA, Howell WM, Kirk M. 2003. Androstenedione and progesterone in the sediment of a river receiving paper mill effluent. Toxicol Sci 73: 53-59.
36. Stanko JP, Angus RA. 2007. In vivo assessment of the capacity of androstenedione to masculinize female mosquitofish (Gambusia affinis) exposed through dietary and static renewal methods. Environ Toxicol Chem 26: 920-926.
37. Sharpe RL, MacLatchy DL, Courtenay SC, Van Der Kraak GJ. 2004. Effects of a model androgen (methyl testosterone) and a model anti-androgen (cyproterone acetate) on reproductive endocrine endpoints in a short-term adult mummichog (Fundulus heteroclitus) bioassay. Aquat Toxicol 67: 203-215.
38. Korsgaard B. 2006. Effects of the model androgen methyltestosterone on vitellogenin in male and female eelpout, Zoarces viviparus (L). Mar Environ Res 62 (Suppl): S205-210.
39. Ankley GT, Jensen KM, Makynen EA, Kahl MD, Korte JJ, Hornung MW, Henry TR, Denny JS, Leino RL, Wilson VS, Cardon MC, Hartig PC, Gray LE. 2003. Effects of the androgenic growth promoter 17-β-trenbolone on fecundity and reproductive endocrinology of the fathead minnow. Environ Toxicol Chem 22: 1350-1360.
40. Kang IJ, Hano T, Oshima Y, Yokota H, Tsuruda Y, Shimasaki Y, Honjo T. 2006. Anti-androgen flutamide affects gonadal development and reproduction in medaka (Oryzias latipes). Mar Environ Res 62 (SupplS253-257).
41. Raut S. 2009. Effects of endocrine disruptors on biomarkers of reproductive function in the western mosquitofish, Gambusia affinis. PhD thesis. University of Alabama at Birmingham, Birmingham, Alabama USA.
42. Crane M, Barrett K, Boxall A, eds. 2008. Veterinary Medicines in the Environment. SETAC, Pensacola, FL, USA.
43. Williams RT, ed. 2005. Human Pharmaceuticals: Assessing Impacts on Aquatic Ecosystems. SETAC, Pensacola, FL, USA.
44. Ankley GT, Brooks BW, Huggett DB, Sumpter JP. 2007. Repeating History: Pharmaceuticals in the Environment. Environ Sci Technol 41: 8211-8217.
45. Gunnarsson L, Jauhiainen A, Kristiansson E, Nerman O, Larsson DGJ. 2008. Evolutionary conservation of human drug targets in organisms used for environmental risk assessments. Environ Sci Technol 42: 5807-5813.
46. Huggett DB, Cook JC, Ericson JF, Williams RT. 2003. A theoretical model for utilizing mammalian pharmacology and safety data to prioritize potential impacts of human pharmaceuticals to fish. HERA 9: 1789-1799.
47. Ankley GT, Bennett RS, Erickson RJ, Hoff DJ, Hornung MW, Johnson RD, Mount DR, Nichols JW, Russom CL, Schmieder PK, Serrrano JA, Tietge JE, Villeneuve DL. 2010. Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem 29: 730-741.
48. Jänne OA, Bardin CW. 1984. Androgen and antiandrogen receptor binding. Annu Rev Physiol 46: 107-118.